AgeX Therapeutics Inc.

AMEX: AGE · Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM

AgeX Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2021 Dec 31, 2020 Dec 31, 2018
Grant Revenues Revenue 56K 77K 104K 307K 20K
Grant Revenues Revenue Growth -27.27% -25.96% -66.12% +1435.00% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 2.91M 2.8M 2.91M 2.32M 1.22M 3.43M 2.17M 1.73M 1.99M 1.58M 1.39M 1.34M 1.66M 1.52M 1.42M 1.75M 2.02M 1.73M 1.95M 1.65M 2.07M 1.72M 2.19M 2.12M 2.11M 1.97M 1.25M 1.14M 1.29M
Selling, General, and Administrative Revenue Growth +3.86% -3.85% +25.31% +90.41% -64.46% +58.06% +25.55% -13.20% +26.06% +13.58% +4.04% -19.40% +9.43% +6.76% -18.71% -13.55% +17.01% -11.34% +17.91% -20.26% +20.73% -21.74% +3.54% +0.47% +7.16% +56.94% +10.48% -12.02% n/a
Research and Development Revenue 2.95M 6.01M 2.42M 1.59M 1.11M 149K 218K 160K 174K 208K 162K 259K 396K 376K 275K 481K 324K 1.19M 839K 1.35M 1.6M 1.47M 1.45M 1.65M 1.34M 1.52M 1.33M 1.38M 2.39M
Research and Development Revenue Growth -50.87% +148.74% +51.51% +44.12% +642.28% -31.65% +36.25% -8.05% -16.35% +28.40% -37.45% -34.60% +5.32% +36.73% -42.83% +48.46% -72.68% +41.36% -37.85% -15.78% +9.12% +1.52% -12.30% +23.32% -12.15% +14.34% -3.76% -42.12% n/a